The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5‐Year Update
Abstract
Purpose: Opioid use disorder (OUD) is a substantial public health problem. Buprenorphine is an effective medication‐assisted treatment (MAT) for OUD, but access is difficult for patients, especially in rural locations. To improve access, the Comprehensive Addiction and Recovery Act of 2016 extended the ability to get a Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine to treat OUD to nurse practitioners (NPs) and physician assistants (PAs). This study summarizes the geographic distribution of waivered physicians, NPs, and PAs at the end of 2017 and compares it to the distribution of waivered physicians 5 years earlier. Methods: Using the DEA list of providers with a waiver to prescribe buprenorphine to treat OUD and the Area Health Resources File, we assigned waivered providers to counties in 1 of 4 geographic categories. We calculated the number of counties in each category that did not have a waivered provider and county provider to population ratios and then compared our results to the waivered workforce in 2012. Findings: The availability of a physician with a DEA waiver to provide office‐based MAT has increased across all geographic categories since 2012. More than half of all rural counties (56.3%) still lack a provider, down from 67.1% in 2012. Almost one‐third (29.8%) of rural Americans compared to 2.2% of urban Americans live in a county without a buprenorphine provider. NPs and PAs add otherwise lacking treatment availability in 56 counties (43 rural). Conclusions: Overall, MAT access has improved, but rural communities still experience treatment disparities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National and state treatment need and capacity for opioid agonist medication-assisted treatment
Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302664 · Cited by 668
Drug Overdose Deaths in the United States, 2002-2022
Spencer, M., Garnett, M., & Miniño, A. (2023) · doi:10.15620/cdc:135849 · Cited by 386
Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder
Rosenblatt, R. A., Andrilla, C. H. A., Catlin, M., & Larson, E. H. (2015) · The Annals of Family Medicine · doi:10.1370/afm.1735 · Cited by 380
Self-citationMack, K. A., Jones, C. M., & Ballesteros, M. F. (2017) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6619a1 · Cited by 253
Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
Thomas, C. P., Fullerton, C. A., Kim, M., Montejano, L., Lyman, D. R., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300256 · Cited by 208
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder
Andrilla, C. H. A., Coulthard, C., & Larson, E. H. (2017) · The Annals of Family Medicine · doi:10.1370/afm.2099 · Cited by 204
Self-citation
Cited by
Comparative effectiveness of different treatment pathways for opioid use disorder.
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20622 · Cited by 995
Telemedicine-delivered treatment interventions for substance use disorders: A systematic review
Lin, L. (., Casteel, D., Shigekawa, E., Weyrich, M. S., Roby, D. H., & McMenamin, S. B. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.03.007 · Cited by 291
Goedel, W. C., Shapiro, A., Cerdá, M., Tsai, J. W., Hadland, S. E., & Marshall, B. D. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3711 · Cited by 295
Haffajee, R. L., Lin, L. A., Bohnert, A. S. B., & Goldstick, J. E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.6373 · Cited by 261
University, F. F., University, L. S., Mexico, V. C., Institute, M. G., & University, F. T. (2023) · Journal of Qualitative Criminal Justice & Criminology · doi:10.21428/88de04a1.d21bf9fc
Metadata
- Authors
- Andrilla, C. H. A., Moore, T. E., Patterson, D. G., & Larson, E. H.
- Venue
- The Journal of Rural Health
- Publisher
- Wiley
- Published
- 2018-06-20
- Volume
- 35
- Issue
- 1
- Pages
- 108-112
- ISSN
- 0890-765X (ISSN-L)
- 1748-0361
- OpenAlex
- W2808922973
- Cited by
- 311
- References
- 6
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5‐Year Update. https://app.cochat.ai/papers/10.1111/jrh.12307
- The paper
- Andrilla, C. H. A., Moore, T. E., Patterson, D. G., & Larson, E. H. (2019). Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5‐Year Update. The Journal of Rural Health. https://doi.org/10.1111/jrh.12307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.